Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale.
about
Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients.Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipientsThe development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.Gametes or organs? How should we legally classify ovaries used for transplantation in the USA?Symptom experienced three years after liver transplantation under immunosuppression in adults.Pilot testing a model of psychological care for heart transplant recipients.A longitudinal study of patients' symptoms before and during the first year after lung transplantation.Adherence of patients to long-term medication: a cross-sectional study of antihypertensive regimens in Austria.What influences persistence with medicines? A multinational discrete choice experiment of 2549 patients.Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation.Depression and Pain in Heart Transplant Recipients: An Observational Study.Health-related quality of life, treatment adherence, symptom experience and depression in adolescent renal transplant patients.Depicting Changes in Multiple Symptoms Over Time.Validation and adaptation of the Modified Transplant Symptom Occurrence and Symptom Distress Scale-59 Items Revised into Turkish.Great expectations? Pre-transplant quality of life expectations and distress after kidney transplantation: a prospective study.Symptom experiences in patients after heart transplantation.Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.
P2860
Q33468225-BA3D3038-8BB3-42DC-8839-1405EA29B75FQ33773992-C2B94638-9CFF-401C-BE04-B02AB9EA2D96Q35010914-2137DFE3-4CE2-40EB-99A9-2B01FC3D2D49Q35012308-47D1935B-F066-4388-95CE-7B95A2FA39BDQ35049135-1C428AED-2FF6-4096-9D2B-00671AAE5C22Q36178876-38AFE7D0-F28D-4C2F-92CA-AB02F0015CB4Q36456710-313EA067-354E-4036-ACCF-23E413415199Q39197284-673266F5-E318-4FEE-897D-AA2FAC4C29D5Q39853880-B689DF2D-ECAA-43D9-8767-98FE8CEF9721Q42175729-B2432BF9-1C73-4852-B889-2C47DBEC2A6FQ43825247-319573CF-EAE4-47D0-BE8C-E67A1AFEC41EQ44996407-8BEC15D8-837E-4DC0-B1A2-69DA634CF881Q45085292-86E81389-53CB-4EFB-88EF-FDC079FA5FFEQ46100025-D58D2953-9D35-462F-8B68-096A140CA236Q47944902-139BE473-99FC-41A9-8138-9DE6E16149A2Q48394879-580D6C26-3C5A-4673-8D5E-184B7F0B3AD2Q50733062-4EA20019-225F-4314-B604-146114EDDEAD
P2860
Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measuring symptom experience o ...... Occurrence and Distress Scale.
@en
Measuring symptom experience o ...... Occurrence and Distress Scale.
@nl
type
label
Measuring symptom experience o ...... Occurrence and Distress Scale.
@en
Measuring symptom experience o ...... Occurrence and Distress Scale.
@nl
prefLabel
Measuring symptom experience o ...... Occurrence and Distress Scale.
@en
Measuring symptom experience o ...... Occurrence and Distress Scale.
@nl
P2093
P50
P1476
Measuring symptom experience o ...... Occurrence and Distress Scale
@en
P2093
Christian P Larsen
Ivo Abraham
Lieven Dupont
P304
P356
10.1111/J.1432-2277.2008.00674.X
P577
2008-05-29T00:00:00Z